Evidence map›Paper›PMID 34280563›Full record

ArticleJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2021

Trends in Accuracy and Comprehensiveness of Pathology Reports for Resected NSCLC in a High Mortality Area of the United States.

Matthew P Smeltzer, Yu-Sheng Lee, Nicholas R Faris M Div, Carrie Fehnel, Olawale Akinbobola, Meghan Meadows-Taylor, David Spencer, Elizabeth Sales, Sherry Okun, Christopher Giampapa and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Matthew P SmeltzerDivision of Epidemiology, Biostatistics, and Environmental Health, School of Public Health, University of Memphis, Memphis, Tennessee.
Yu-Sheng LeeDivision of Epidemiology, Biostatistics, and Environmental Health, School of Public Health, University of Memphis, Memphis, Tennessee.
Nicholas R Faris M DivMultidisciplinary Thoracic Oncology Program, Baptist Cancer Center, Memphis, Tennessee.
Carrie FehnelMultidisciplinary Thoracic Oncology Program, Baptist Cancer Center, Memphis, Tennessee.
Olawale AkinbobolaMultidisciplinary Thoracic Oncology Program, Baptist Cancer Center, Memphis, Tennessee.
Meghan Meadows-TaylorMultidisciplinary Thoracic Oncology Program, Baptist Cancer Center, Memphis, Tennessee.
David SpencerTrumbull Laboratories, LLC, Memphis, Tennessee.
Elizabeth SalesDoctors Anatomic Pathology Services, P.A., Jonesboro, Arkansas.
Sherry OkunTupelo Pathology Group, P.C., Tupelo, Mississippi.
Christopher GiampapaJackson Pathology Group, Jackson, Tennessee.
Amal AngaVA Department of Pathology, Memphis, Tennessee.
Alicia PachecoMultidisciplinary Thoracic Oncology Program, Baptist Cancer Center, Memphis, Tennessee.
Meredith A RayDivision of Epidemiology, Biostatistics, and Environmental Health, School of Public Health, University of Memphis, Memphis, Tennessee.
Raymond U OsarogiagbonMultidisciplinary Thoracic Oncology Program, Baptist Cancer Center, Memphis, Tennessee. Electronic address: rosarogi@bmhcc.org.
University of Memphis · USBaptist Memorial Hospital · USJackson Memorial Hospital · USMemphis VA Medical Center · US

Funding

Improving pathologic nodal staging of resected lung cancerR01CA172253 · NCI · UNIVERSITY OF MEMPHIS · PI OSAROGIAGBON, RAYMOND U · 2013 to 2022
$4.8M
NCI NIH HHS R01 CA172253
6 · The paper itself

Abstract

introductionComplete and accurate pathology reports are vital to postoperative prognostication and management. We evaluated the impact of three interventions across a diverse group of hospitals on pathology reports of postresection NSCLC.

methodsWe evaluated pathology reports for patients who underwent curative-intent surgical resection for NSCLC, at 11 institutions within four contiguous Dartmouth Hospital Referral Regions in Arkansas, Mississippi, and Tennessee from 2004 to 2020, for completeness and accuracy, before and after the following three quality improvement interventions: education (feedback to heighten awareness); synoptic reporting; and a lymph node specimen collection kit. We compared the proportion of pathology reports with the six most important items for postoperative management (specimen type, tumor size, histologic type, pathologic [p] T-category, pN-category, margin status) across the following six patient cohorts: preintervention control, postintervention with four different combinations of interventions, and a contemporaneous nonintervention external control.

resultsIn the postintervention era, the odds of reporting all key items were eight times higher than those in the preintervention era (OR = 8.3, 95 % confidence interval [CI]: 6.7-10.2, p < 0.0001). There were sixfold and eightfold increases in the odds of accurate pT- and pN-category reporting in the postintervention era compared with the preintervention era (pT OR = 5.7, 95 % CI: 4.7-6.9; pN OR = 8.0, 95 % CI: 6.5-10.0, both p < 0.0001). Within the intervention groups, the odds of reporting all six key items, accurate pT category, and accurate pN-category were highest in patients who received all three interventions.

conclusionsGaps in the quality of NSCLC pathologic reportage can be identified, quantified, and corrected by rationally designed interventions.

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsHumansLymph NodesUnited StatesLymph node kitNSCLCQuality improvementSynoptic reporting

Identifiers

PMID34280563
PMCPMC9039869
OpenAlexW3182646639

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.